One study noted 17 cytokines had a significant upward linear trend with the severity of ME/CFS: CCL11 (Eotaxin-1), CXCL1 (GRO), CXCL10 (IP-10), IFN (interferon)-y, interleukin (IL)-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, G-CSF, GM-CSF, LIF, NGF, SCF, and TGF- (231)
Commentary: Bioavailability of flavonoids and polyphenols: Call to arms
Once a patient is in a safe environment, the clinical focus shifts to repairing cellular damage and upregulating the liver's natural detoxification pathways
Beyond their well-characterised effects on lowering blood glucose and body weight, GLP-1 medicines have been shown to improve outcomes in people with cardiovascular, kidney, liver, arthritis, and sleep apnea disorders
Whilst pharmacological combinations remain clinically unsupported for retatrutide at this stage, there is robust evidence that certain lifestyle interventions can meaningfully complement weight-loss pharmacotherapy
Our physicians may recommend or prescribe other GLP-1 options depending on availability and individual preferences
